<DOC>
	<DOCNO>NCT01043211</DOCNO>
	<brief_summary>The purpose study generate insight role effectiveness amide local anesthetic lidocaine adjuvant postoperative analgesic adult spine surgery . The effect perioperative intravenous lidocaine infusion postoperative rehabilitation inflammatory response also examine .</brief_summary>
	<brief_title>Analgesic Efficacy Intravenous Lidocaine Postoperative Pain Following Adult Spine Surgery</brief_title>
	<detailed_description>Inadequate pain control spine surgery adult result increased patient morbidity length hospital stay , whereas improve postoperative pain control demonstrate numerous physiologic benefit reduce postoperative complication . When administer systemically , amide local anesthetic lidocaine potent anti-inflammatory property , include inhibition arachidonic acid cascade production eicosanoids prostaglandin . Previous study confirm continuous intravenous administration lidocaine abdominal surgery adult improve patient rehabilitation ( specifically , pain intensity , duration ileus , incidence nausea vomit ) , shorten hospital stay . The beneficial anti-inflammatory property versus untoward side effect local anesthetic appear superior steroid non-steroidal anti-inflammatory drug ( NSAIDs ) . Moreover , concern controversy exist regard adverse effect NSAIDs bone healing , particularly adult undergo spine surgery . No study date investigate efficacy continuous perioperative lidocaine infusion adult spine surgery population . Therefore , prospective , randomize , control trial , evaluate analgesic efficacy , anti-inflammatory property , rehabilitation pattern continuous , perioperative intravenous infusion lidocaine versus normal saline placebo adult patient undergo decompressive lumbar laminectomy spinal canal stenosis . Subjects enrol study receive standardize general anesthetic consistent present clinical practice . The study participant randomize receive perioperative bolus ( 2 mg/kg ) subsequent intravenous infusion ( 3 mg/kg/hr ) amide local anesthetic lidocaine normal saline placebo equal volume per hour . The study infusion continue 90 minute surgery . All patient receive ample adequate intravenous dos opioid ( morphine sulfate ) reduce pain intensity acceptable level . Pain intensity , opioid requirement , opioid-related side effect , immediate sustain rehabilitation pattern assess . In addition plasma lidocaine level active drug group , plasma C-reactive protein , cortisol , cytokine level ( e.g. , IL-6 , IL-10 TNF-Î± ) obtain series perioperative time point study patient . Postoperative cytokine level also measure surgical drainage fluid .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<criteria>1 . 19 year 80 year age 2 . American Society Anesthesiologists 13 status 3 . Undergoing lumbar laminectomy level L1 S1 decompression degenerative lumbar canal stenosis without fusion internal fixation perform 1 . American Society Anesthesiologists 4 status 2 . Previous spinal fusion surgery patient may undergo previous lumbar laminectomy lumbar open discectomy 3 . Morbid obesity ( BMI &gt; 40 ) 4 . Diagnosis spinal metastatic cancer 5 . Presence severe systemic bacterial infection 6 . Allergy amide local anesthetic morphine sulfate 7 . History seizure disorder 8 . History atrial ventricular arrhythmia 9 . History autonomic dysfunction ( e.g. , dysautonomia diabetes ) 10 . History renal dysfunction , liver dysfunction congestive heart failure 11 . History substance abuse disorder 12 . History major psychiatric disorder ( e.g. , depression , bipolar disorder , Axis II personality disorder , schizophrenia ) 13 . Chronic opioid use great 100 mg/day morphine equivalent within 30 day prior surgery 14 . Current use corticosteroid 15 . Use nonsteroidal antiinflammatory drug ( NSAID ) , include low dose aspirin within past 5 day 16 . Use arrhythmic drug within past 7 day 17 . Current administration know potent CYP1A2 inhibitor , include zileuton ( Zyflo ) , ciprofloxacin , enoxacin fluoroquinolone antibiotic , amiodarone , mexiletine , propafenone , verapamil , cimetidine ( Tagamet ) , famotidine ( Pepcid ) , oral contraceptive , acyclovir ( Zovirax ) ticlopidine ( Ticlid ) ( Horn &amp; Hansten , 2008 ) . 18 . Current administration know potent CYP3A4 inhibitor , include erythromycin , clarithromycin , azole antifungal ( ketoconazole , fluconazole ) , verapamil , diltiazem , grapefruit juice ( Scuderi et al. , 2006 ) . 19 . Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Back Pain</keyword>
	<keyword>Lidocaine</keyword>
</DOC>